Amgen recalls nearly 1M heart and kidney meds over tablet contamination

Nearly 1 million bottles (about 944,142) of Amgen medications Corlanor (ivabradine) and Sensipar (cinacalcet) have been recalled nationwide after foreign matter was found on the exterior surface of tablets in a reserve sample. The issue was localized to the coating and occurred in bottles packaged in AML Building 23; the recalls cover multiple dosages and bottle counts distributed from Oct 28, 2021 to Dec 30, 2025. The FDA classified the recall as Class II with low overall patient-safety risk, and there have been no reported complaints.